ReviewMolecules (Basel, Switzerland)2026
An Overview of Metabolomic Approaches to Polyphenol Profiling for Nutraceutical Development.
Review in Molecules (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Secondary plant metabolites such as polyphenols (flavonoids, phenolic acids, stilbenes, and lignans) are valued for their numerous benefits and commonly associated with antioxidants, anti-inflammatory, anticancer, neuroprotective, and antidiabetic effects. Comprehensive profiling facilitates their identification and quantification, with metabolomics emerging as an increasingly valuable tool. This current work provides an overview of recent application of metabolomics for investigating polyphenols with nutraceutical potential. It also highlights the influence of plant species and environmental stressors (both biotics and abiotic) inducing metabolic shifts that promote the production and accumulation of these bioactive compounds (BACs). While various analytical tools including mass spectrometry (MS) coupled with liquid chromatography (LC-MS) or gas chromatography (GC-MS), as well as nuclear magnetic resonance (NMR) spectroscopy have been utilized to identify the diverse group of polyphenol metabolites, LC-MS has been predominantly used due to its superior sensitivity and wider metabolite coverage, with flavonoids being the main compounds identified. The integration of bioinformatic tools and pathway enrichment analysis in metabolomics is providing expansive insight into the pool of polyphenols, and their bio-functional interpretation and metabolic variations beyond the narrow scope of chromatographic separation alone. This overview also identifies limitations of current methods and suggests directions for future research, aimed at facilitating the development of nutraceuticals.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.